health biotech news today obesity drugs glp-1 Weight loss without side effects? Top researchers propose new approach Healthy Returns: Obesity pills from

In conclusion, while GLP-1RAs and GLP-1/GIP dual agonists offer significant clinical advantages, ongoing research and vigilant monitoring of their adverse effects and safety are essential for optimizing their therapeutic application.229,230 Conclusion In summary, GLP-1RAs and dual-receptor agonists targeting both GLP-1 and GIP receptors have introduced significant advancements in the management of endocrine and metabolic disorders and their associated complications, establishing themselves as central therapeutic modalities within this domain

GLP-1s are used primarily to treat people with Type 2 diabetes and, in some cases, obesity

That stimulation might be causing a cascade of other chemical changes that ultimately affects mood

Some protein-rich foods help to prevent the de-activation of GLP-1 (Miguens-Gomez 2021)

Soda versus cereal and sugar versus fat: Drivers of healthful food intake and the impact of diabetes diagnosis

2024 and that analysis was done before the recent CVS Caremark decision to drop coverage for the drug starting in July